gallstones and semaglutide Ozempic (semaglutide) has been associated with an increased risk of cholelithiasis (gallstones) other gallbladder diseases., The mechanism of action (MOA) behind this increased risk involves a Can Semaglutide Cause Gallbladder Issues?

They contain the same active ingredient (semaglutide) but are not the same product

Novo Nordisk has manufactured multiple GLP-1 receptor agonist products, which include not just semaglutide but liraglutide, to treat obesity and diabetes while broadening the use of GLP-1 receptor agonists in treating these conditions

In addition to medication accessibility, we offer clinical oversight, metabolic testing as necessary, and ongoing support from board-certified physicians

Attention to abdominal fat distribution is particularly relevant for identifying those people who, despite being of normal weight, have increased waist circumference values and are therefore considered living with metabolically obesity or rather burdened with cardio-metabolic complications [3]